These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2476614)

  • 1. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
    Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect kinetics of N-acetylprocainamide-induced QT interval prolongation.
    Piergies AA; Ruo TI; Jansyn EM; Belknap SM; Atkinson AJ
    Clin Pharmacol Ther; 1987 Jul; 42(1):107-12. PubMed ID: 2439251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
    Atkinson AJ; Ruo TI; Piergies AA
    Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide.
    Kosoglou T; Rocci ML; Vlasses PH
    Clin Pharmacol Ther; 1988 Oct; 44(4):467-77. PubMed ID: 2458879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes induced by N-acetylprocainamide.
    Chow MJ; Piergies AA; Bowsher DJ; Murphy JJ; Kushner W; Ruo TI; Asada A; Talano JV; Atkinson AJ
    J Am Coll Cardiol; 1984 Sep; 4(3):621-4. PubMed ID: 6206104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of N-acetylprocainamide in long-term treatment of ventricular arrhythmias.
    Atkinson AJ; Lertora JJ; Kushner W; Chao GC; Nevin MJ
    Clin Pharmacol Ther; 1983 May; 33(5):565-76. PubMed ID: 6188570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide.
    Winkle RA; Jaillon P; Kates RE; Peters F
    Am J Cardiol; 1981 Jan; 47(1):123-30. PubMed ID: 6161534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
    Tisdale JE; Rudis MI; Padhi ID; Svensson CK; Webb CR; Borzak S; Ware JA; Krepostman A; Zarowitz BJ
    J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and pharmacodynamics of procainamide in horses after intravenous administration.
    Ellis EJ; Ravis WR; Malloy M; Duran SH; Smyth BG
    J Vet Pharmacol Ther; 1994 Aug; 17(4):265-70. PubMed ID: 7525982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ; Ruo TI
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined pharmacokinetic and pharmacodynamic model analysis for procainamide and its metabolite].
    Liu XQ; Huang SK
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):7-11. PubMed ID: 1719744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide.
    Vlasses PH; Kosoglou T; Chase SL; Greenspon AJ; Lottes S; Andress E; Ferguson RK; Rocci ML
    Arch Intern Med; 1989 Jun; 149(6):1350-3. PubMed ID: 2471472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.
    Sonnhag C; Karlsson E
    Eur J Clin Pharmacol; 1979 Jun; 15(5):311-7. PubMed ID: 378673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects of N-acetylprocainamide in human beings.
    Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
    Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetylprocainamide kinetics and clinical response during repeated dosing.
    Rodman JH; Hurst A; Gaarder T; Cohen J; Jelliffe RW
    Clin Pharmacol Ther; 1982 Sep; 32(3):378-86. PubMed ID: 6179685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions.
    Atkinson AJ; Lee WK; Quinn ML; Kushner W; Nevin MJ; Strong JM
    Clin Pharmacol Ther; 1977 May; 21(5):575-87. PubMed ID: 322922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
    Bruguerolle B; Jadot G
    J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.